Organogenesis (ORGO) News Today $4.04 +0.07 (+1.76%) (As of 10:25 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Cantor Fitzgerald Comments on Organogenesis FY2024 EarningsNovember 19 at 1:53 AM | americanbankingnews.comAnalysts Set Expectations for Organogenesis FY2024 EarningsOrganogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) - Research analysts at Cantor Fitzgerald raised their FY2024 EPS estimates for Organogenesis in a report released on Wednesday, November 13th. Cantor Fitzgerald analyst R. Osborn now expects that the company will post earnings per share of (November 18 at 1:49 AM | marketbeat.comMorgan Stanley Sticks to Their Hold Rating for Organogenesis Holdings (ORGO)November 15, 2024 | markets.businessinsider.comOrganogenesis ‘commends’ final local coverage determinationsNovember 15, 2024 | markets.businessinsider.comOrganogenesis (NASDAQ:ORGO) Announces Earnings Results, Beats Estimates By $0.11 EPSOrganogenesis (NASDAQ:ORGO - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.11. The company had revenue of $115.18 million during the quarter, compared to analysts' expectations of $109.59 million. Organogenesis had a negative return on equity of 2.69% and a negative net margin of 1.62%. During the same period in the previous year, the business earned $0.02 earnings per share.November 15, 2024 | marketbeat.comOrganogenesis Commends Final LCDsNovember 15, 2024 | globenewswire.comOrganogenesis Reports Robust Third Quarter GrowthNovember 14, 2024 | markets.businessinsider.comOrganogenesis (NASDAQ:ORGO) Shares Gap Down - Here's What HappenedOrganogenesis (NASDAQ:ORGO) Shares Gap Down - Here's WhyNovember 14, 2024 | marketbeat.comOrganogenesis Holdings Secures $130M Investment for GrowthNovember 14, 2024 | markets.businessinsider.comOrganogenesis Holdings Inc. Reports Third Quarter 2024 Financial ResultsNovember 13, 2024 | markets.businessinsider.comOrganogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...November 13, 2024 | finance.yahoo.comOrganogenesis (ORGO) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | fool.comOrganogenesis Holdings, Inc. (ORGO) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comOrganogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred StockNovember 12, 2024 | globenewswire.comOrganogenesis Holdings Inc.: Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee OsteoarthritisNovember 12, 2024 | finanznachrichten.deOrganogenesis provides update on Phase 3 trial of ReNu in knee osteoarthritisNovember 12, 2024 | markets.businessinsider.comOrganogenesis Holdings (ORGO) Receives a Buy from Lake StreetNovember 12, 2024 | markets.businessinsider.comOrganogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee OsteoarthritisNovember 11, 2024 | globenewswire.comOrganogenesis (ORGO) Scheduled to Post Quarterly Earnings on TuesdayNovember 11, 2024 | americanbankingnews.comOrganogenesis (ORGO) Set to Announce Quarterly Earnings on TuesdayOrganogenesis (NASDAQ:ORGO) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636063)November 5, 2024 | marketbeat.comOrganogenesis Holdings And 2 Other US Penny Stocks To WatchNovember 4, 2024 | uk.finance.yahoo.comMass. company offered millions to manufacture artificial skin in the Ocean StateOctober 31, 2024 | bizjournals.comBoston biotech aims to put some skin in the RI life sciences gameOctober 31, 2024 | bizjournals.comShareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested three years agoOctober 30, 2024 | finance.yahoo.comAssenagon Asset Management S.A. Has $5.48 Million Stake in Organogenesis Holdings Inc. (NASDAQ:ORGO)Assenagon Asset Management S.A. cut its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 51.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,915,729 shares of the company'October 30, 2024 | marketbeat.comOrganogenesis Hldgs (NASDAQ:ORGO) Stock, Option ChainOctober 24, 2024 | benzinga.comOrganogenesis Hldgs (NASDAQ:ORGO) Stock, Short Interest ReportOctober 23, 2024 | benzinga.comOrganogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024October 16, 2024 | globenewswire.comOrganogenesis (ORGO) Shows Fast-paced Momentum But Is Still a Bargain StockOctober 15, 2024 | msn.comOrganogenesis: Lurking Disruption With Recovery To FollowOctober 14, 2024 | seekingalpha.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Expected to Earn FY2024 Earnings of ($0.17) Per ShareOrganogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) - Stock analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of Organogenesis in a report issued on Wednesday, October 9th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings pOctober 11, 2024 | marketbeat.comDimensional Fund Advisors LP Buys 333,123 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Dimensional Fund Advisors LP raised its stake in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 19.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 2,036,743 shares of the company's stock after purchasing an additional 333,123 sharesOctober 9, 2024 | marketbeat.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Shares Purchased by AQR Capital Management LLCAQR Capital Management LLC raised its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 76.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,268,760 shares of the company's stock after buying an additional 986,132 shOctober 4, 2024 | marketbeat.comOrganogenesis Holdings (ORGO) Receives a Buy from Cantor FitzgeraldOctober 3, 2024 | markets.businessinsider.comOrganogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot UlcersOctober 1, 2024 | globenewswire.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Down 16.5% in SeptemberOrganogenesis Holdings Inc. (NASDAQ:ORGO - Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 11,680,000 shares, a drop of 16.5% from the August 31st total of 13,990,000 shares. Based on an average daily trading volume, of 723,500 shares, the days-to-cover ratio is presently 16.1 days. Approximately 15.0% of the company's stock are short sold.September 28, 2024 | marketbeat.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Wealth Dimensions Group Ltd.Wealth Dimensions Group Ltd. increased its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 435.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 407,965 shares of the company'September 16, 2024 | marketbeat.comOrganogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in SeptemberSeptember 4, 2024 | globenewswire.comAssenagon Asset Management S.A. Has $11.14 Million Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO)Assenagon Asset Management S.A. grew its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 309.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,977,124 shares of the companyAugust 17, 2024 | marketbeat.comVanguard Group Inc. Sells 1,825,428 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)Vanguard Group Inc. lowered its stake in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 34.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,535,299 shares of the company's stock after selling 1,August 15, 2024 | marketbeat.comOrganogenesis Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsAugust 12, 2024 | finance.yahoo.comOrganogenesis Holdings Inc. Reports Second Quarter 2024 Financial ResultsAugust 9, 2024 | markets.businessinsider.comOrganogenesis (ORGO) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | msn.comOrganogenesis Shares ReNu® Program UpdateAugust 8, 2024 | globenewswire.comOrganogenesis (ORGO) to Release Earnings on ThursdayOrganogenesis (NASDAQ:ORGO) will be releasing earnings after the market closes on Thursday, August 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=608809)August 1, 2024 | marketbeat.comOrganogenesis Holdings Inc. (NASDAQ:ORGO) Shares Purchased by Acadian Asset Management LLCAcadian Asset Management LLC grew its holdings in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 18.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,001,679 shares of the company's stock after purchasing an additional 471July 22, 2024 | marketbeat.comOrganogenesis Holdings Inc. (ORGO): Is It Among the Best NASDAQ Penny Stocks to Invest In Now?July 20, 2024 | finance.yahoo.comOrganogenesis Holdings Inc (2PQ.DU)July 19, 2024 | finance.yahoo.comOrganogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024July 15, 2024 | globenewswire.comGSA Capital Partners LLP Purchases 269,315 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)GSA Capital Partners LLP lifted its stake in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 102.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 531,218 shares of the company'sJuly 11, 2024 | marketbeat.com Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. ORGO Media Mentions By Week ORGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORGO News Sentiment▼0.700.46▲Average Medical News Sentiment ORGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORGO Articles This Week▼121▲ORGO Articles Average Week Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MiMedx Group News Integra LifeSciences News Akero Therapeutics News Amphastar Pharmaceuticals News Mirum Pharmaceuticals News NewAmsterdam Pharma News Apogee Therapeutics News Disc Medicine News Centessa Pharmaceuticals News Harmony Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORGO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organogenesis Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organogenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
